Sunday, 31 August 2014

Neglected Tropical Diseases (NTD) of the Developing World



FDA: Guidance for Industry Neglected Tropical Diseases (NTD) of the Developing World: Developing Drugs for Treatment or Prevention

The purpose of this guidance is to assist sponsors in the development of drugs for the treatment or prevention of NTDs of the developing world. Specifically, it addresses the Food and Drug Administration’s (FDA’s) current thinking regarding the overall drug development program for the treatment or prevention of NTDs, including clinical trial designs and internal review standards to support approval of drugs.

For details, see FDA

Posted by Tim Sandle